Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells
Authors:
- Li ZhangLZLi Zhang
- Li LiLLLi Li
- 8 November 2012
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 40 (1) , 1-6
Abstract
Previous researches have showed that HSP90AA is important in ovarian cancer, but the mechanism of HSP90AA is still unknown. This study aimed to investigate the role of the potential therapy target protein HSP90AA1 in ovarian cancer. The level of HSP90AA1 in ovarian cancer SKOV3 cell line was altered by RNAi and overexpression. Survival of these cell lines was investigated by tetrazolium-based assay and fluorescence-activated cell sorter (FACS). The chemosensitivity to cisplatin of the cell was also tested by FACS when HSP90AA1 was overexpressed. HSP90AA1 RNAi inhibited the proliferation of ovarian cancer SKOV3 cell line and increased the apoptosis. Furthermore, overexpression of HSP90AA1 decreased the chemosensitivity to cisplatin of SKOV3 cells and overexpression of HSP90AA1 could partially rescue the survival rate of SKOV3 cells which were treated with cisplatin. HSP90AA1 is required for the survival and proliferation of SKOV3 cells. High level of HSP90AA1 can increase chemoresistance to cisplatin of SKOV3 cells.Keywords
This publication has 25 references indexed in Scilit:
- Combined Effect of Hsp90 Inhibitor Geldanamycin and Parthenolide via Reactive Oxygen Species‐Mediated Apoptotic Process on Epithelial Ovarian Cancer CellsBasic & Clinical Pharmacology & Toxicology, 2012
- Heat Shock Protein 90 as a Drug Target: Some Like It HotClinical Cancer Research, 2008
- Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosisFertility and Sterility, 2006
- Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2005
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patientsOncogene, 2004
- Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasivenessNature Cell Biology, 2004
- Heat shock protein 90Current Opinion in Oncology, 2003
- Expression of heat‐shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovariesAPMIS, 2003
- Current treatment for ovarian cancerExpert Opinion on Pharmacotherapy, 2001